Thienothiadiazine 2,2-dioxide acyclonucleosides: Synthesis and antiviral activity

Antiviral Chemistry and Chemotherapy

Volumn 11, Issue 3, 2000, Pages 221-230

  Martinez, A ^a   Esteban, Al ^a   Castro, A ^a   Gil, C ^a   Conde, S ^a   Andrei, G ^b   Snoeck, R ^b   Balzarini, J ^b   De Clercq, E ^b  

^a INSTITUTO DE QUÍMICA MÉDICA   (Spain)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Acyclonucleosides.; Antiviral; HCMV; HIV; Thienothiadiazines

Indexed keywords

ACYCLIC NUCLEOSIDE; BENZYL DERIVATIVE; CIDOFOVIR; FOSCARNET; GANCICLOVIR; THIADIAZINE DERIVATIVE; THIENOTHIADIAZINE 2,2 DIOXIDE ACYLONUCLEOSIDE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VARICELLA ZOSTER VIRUS;

EID: 0033946410     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020001100305     Document Type: Article

References (25)

1. Albert A & Serjeant EP (1971) Determination of ionization constants. pp. 171-190. London: Chapman and Hall.
2. Andrei G, Snoeck R, Reymen D, Liesnard C, Goubau P, Desmyter J & De Clercq E (1995) Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus. European Journal of Clinical Microbiology and Infectious Diseases 14:318-328.
3. Arán VJ, Goya P & Ochoa C (1988) Heterocycles containing the sulfamide moiety. Advances in Heterocyclic Chemistry 44:81-197.
4. Bax A & Subramanian B (1986) Sensivity-enhanced two-dimensional heteronuclear shift correlation NMR spectroscopy. Journal of Magnetic Resonance 67:565-568.
5. Bax A & Summers MF (1988) Proton and carbon-13 assignments from sensivity-enhanced detection of heteronuclear multiple-bond connectivity by 2D multiple quantum NMR. Journal of the American Chemical Society 108:2093-2099.
6. 2-uracil analog diacyclonucleosides. Long-distance effect of the substituents on the regioselectivity. Journal of Molecular Catalysis 4:295-302.
7. Esteban AI, Juanes O, Martinez A & Conde S (1994) Regioselective lipase-mediated acylation-deacylation in thiadiazine diacyclonucleosides. Tetrahedron 50:13865-13873.
8. Esteban AI, Juanes O, Goya P, Conde S, De Clercq E & Martinez A (1995) New 1,2,6-thiadiazine dioxide acyclonudeosides: Synthesis and antiviral evaluation. Bioorganic and Medicinal Chemistry Letters 3:1527-1535.
9. Esteban AI, De Clercq E & Martinez A (1997) Synthesis and antiviral activity of modified 1,2,6-thiadiazine dioxide acyclonucleosides. Nucleosides & Nucleotides 16:265-276.
10. De Clercq E (1994) In vitro and ex vivo test systems to rationalize drug design and delivery. In Minutes of an European Symposium. pp. 108-125. Edited by D Crommelin, P Couvreur and D Duchêne. Paris: Editions de Santé.
11. De Clercq E (1995) Trends in the development of new antiviral agents for the chemotherapy of infections caused by herpesviruses and retroviruses. Reviews in Medical Virology 5:149-164.
12. Frisch MJ, Trucks GW, Schlegel HB, Gill PMW, Johnson BG, Robb MA, Cheeseman JR, Keith T, Petersson GA, Montgomery JA, Raghavachari K, Al-Laham MA, Zakrzewski VG, Ortiz JV, Foresman JB, Peng CY, Ayala PY, Chen W, Wong MW, Andres JL, Replogle ES, Gomperts R, Martin RL, Fox DJ, Binkley JS, Defrees DJ, Baker J, Stewart JPP, Head-Gordon M, Gonzalez C & Pople JA (1995) Gaussian 94, Revision D.4. Pittsburgh: Gaussian Inc.
13. Gewald K, Elfriede S & Bötter H (1966) 2-Amino-thiophene aus methylenaktiven nitrilen, carbonylverbindungen und schwefel. Chemische Berichte 99:94-100.
14. Jong MD, Boucher CAB, Danner SA, Gazzard B, Griffiths PD, Katlama C, Lange JMA, Richman DD & Vella S (1998) Summary of the international consensus symposium on management of HIV, CMV and hepatitis virus infections. Antiviral Research 37:1-16.
15. Kloek JA & Leschinsky KL (1978) Cyclic sulfamides: Synthesis of some fused tetrahydrobenzo- and tetra- and dihydroheterothiadiazinone 2,2-dioxides. Journal of of Organic Chemistry 43:3824-3827.
16. Martinez A, Esteban AI & De Clercq E (1997) Benzothiadiazine dioxide acyclonudeosides as lead compounds for the development of new agents against human cytomegalovirus and varicella-zoster virus infections. Bioorganic and Medicinal Chemistry Letteres 7:1031-1032.
17. Martinez A, Esteban AI, Castro A, Gil C, Conde S, Andrei G, Snoeck R, Balzarini J & De Clercq E (1999a) Novel potential agents for human cytomegalovirus infection: Synthesis and anti-viral activity evaluation of benzothiadiazine dioxide acyclonucleosides. Journal of Medicinal Chemistry 42:1145-1150.
18. Martinez A, Esteban AI, Herrero A, Ochoa C, Andrei G, Snoeck R, Balzarini J & De Clercq E (1999b) Imidazothiadiazine dioxides: Synthesis and antiviral activity. Bioorganic and Medicinal Chemistry 7:1617-1623.
19. Niedballa U & Vorbrüggen H (1974) A general synthesis of N-glycosides. Journal of Organic Chemistry 39:3654-3660.
20. Pinto IL, West A, Debouck CM, DiLella AG, Gorniak JG, O'Donell KC, O'Shannessy DJ, Patel A & Jarvest RL (1996) Novel, selective mechanism-based inhibitors of the herpes proteases. Bioorganic and Medicinal Chemistry Letters 6:2467-2472.
21. Renault J, Laudree D & Robba M (1994) Synthesis and antiviral study of dihydrothieno and thianopyrimidine diones acyclic nucleosides as potential anti-HIV agents. Nucleosides & Nucleotides 13:1135-1145.
22. Rosowsky A, Kim SH & Wick M (1981) Synthesis and antitumor activity of an acyclonucleoside derivative of 5-fluoruracil. Journal of Medicinal Chemistry 24:1177-1181.
23. Rozas I (1987) 1,2,6-Thiadiazine 1,1-dioxides: new derivatives synthesis and physico-chemical properties study. PhD Thesis, Madrid: Complutense University.
24. Snoeck R, Schols D, Andrei G, Neyts J & De Clercq E (1991) Antiviral activity of anticytomegalovirus agents (HPMPC, HPMPA) assessed by a flow-cytometric method and DNA hybridization technique. Antiviral Research 16:1-9.
25. Van der Meer JTM, Drew WL, Bowden RA, Galasso GJ, Griffiths PD, Jabs DA, Katlama C, Spector SA & Whitley RJ (1996) Summary of the international consensus symposium on advances in the diagnosis, treatment and prophylaxis of cytomegalovirus infection. Antiviral Research 32:119-140.